Xenon Pharmaceuticals Inc. (XENE) has a consensus analyst rating of Buy, based on 22 analysts covering the stock. Of those, 22 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for XENE is $76.67, representing a +29.2% upside from the current price of $59.35. Price targets range from a low of $44.00 to a high of $100.00.
